Thomas Hielscher

机构：German Cancer Research Center, Heidelberg University, Heidelberg Engineering (Germany), DKFZ-ZMBH Alliance

发表论文 514 篇 · 总被引 21078 次 · h-index 63

代表论文

Prognostic value of circulating tumor DNA and copy-number alterations in patients receiving tandem [225 Ac]Ac-/[177 Lu]Lu-PSMA-617 therapy for metastatic castration- resistant prostate cancer: a prospective observational study (2026 · Research Square)
Supplementary Table S9 from Clinical Scores to Predict Toxicities and Outcomes in Patients with Multiple Myeloma Undergoing Bispecific T-cell Engager Therapy (2026)
Supplementary Table S3 from Clinical Scores to Predict Toxicities and Outcomes in Patients with Multiple Myeloma Undergoing Bispecific T-cell Engager Therapy (2026)
Supplementary Table S13 from Clinical Scores to Predict Toxicities and Outcomes in Patients with Multiple Myeloma Undergoing Bispecific T-cell Engager Therapy (2026)
Supplementary Table S12 from Clinical Scores to Predict Toxicities and Outcomes in Patients with Multiple Myeloma Undergoing Bispecific T-cell Engager Therapy (2026)
Supplementary Table S10 from Clinical Scores to Predict Toxicities and Outcomes in Patients with Multiple Myeloma Undergoing Bispecific T-cell Engager Therapy (2026)